BANK OF MONTREAL /CAN/
BankPosition in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 927971
TORONTO, A6
Position in VRTX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$174,363,150
-$19,439,178 QoQ
Shares Held
390,476
-8.7% QoQ
Ownership
0.154%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 96.07683954967783.ToString("F0")%
Shared 0.ToString("F0")%
None 3.923160450322171.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF MONTREAL /CAN/ holds $580,215,891 across 80 Biotechnology names. VRTX ranks #1 (30.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
390,476 | $174,363,150 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,055,597 | $68,223,231 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
85,524 | $66,079,260 | |
| 4 | ARGX |
Argenx SE
|
85,333 | $62,314,421 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
239,265 | $45,233,045 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
86,183 | $17,206,434 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
515,328 | $17,119,195 | |
| 8 | INCY |
Incyte Corp
|
171,790 | $16,168,871 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $174,363,150 | 390,476 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $193,802,328 | 427,480 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $164,276,527 | 419,458 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $161,623,178 | 363,035 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $200,563,726 | 413,687 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $234,041,585 | 581,181 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $259,150,477 | 557,217 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $239,716,529 | 511,428 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $211,973,704 | 507,102 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $233,606,532 | 574,127 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $181,991,116 | 523,354 | Shares | Defined | 2023-11-01 | |
| 2023-06-30 | $168,183,065 | 477,915 | Shares | Defined | 2023-08-02 | |
| 2023-03-31 | $137,823,588 | 437,438 | Shares | Defined | 2024-06-13 | |
| 2022-12-31 | $106,271,326 | 368,001 | Shares | Defined | 2023-02-01 | |
| 2022-09-30 | $79,754,948 | 275,454 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $106,067,162 | 376,405 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $96,943,305 | 371,473 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $75,075,528 | 341,874 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $191,068,784 | 1,053,359 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $189,295,078 | 938,824 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $175,216,358 | 815,377 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $111,779,836 | 472,962 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $104,476,116 | 383,934 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $136,978,414 | 471,835 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $115,984,915 | 487,434 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||